Beta-adrenoceptor-blocking agents in the management of hypertension.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000526:Alprenolol / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D004341:Drug Evaluation; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D009474:Neurons / Q000187:drug effects; D010096:Oxprenolol / Q000627:therapeutic use; D005082:Physical Exertion; D010953:Plasma Volume / Q000187:drug effects; D011311:Pressoreceptors / Q000187:drug effects; D011433:Propranolol / Q000627:therapeutic use; D012083:Renin / Q000097:blood; D013696:Temperature; D014636:Valsalva Maneuver
D000319:Adrenergic beta-Antagonists; D010096:Oxprenolol; D000526:Alprenolol; D011433:Propranolol; D012083:Renin